{"title": "Big data study identifies drugs that increase risk of psychosis in youth with ADHD", "title_detail": {"type": "text/plain", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmacology.xml", "value": "Big data study identifies drugs that increase risk of psychosis in youth with ADHD"}, "links": [{"rel": "alternate", "type": "text/html", "href": "https://www.sciencedaily.com/releases/2019/03/190320171704.htm"}], "link": "https://www.sciencedaily.com/releases/2019/03/190320171704.htm", "summary": "Researchers evaluated the two most common ADHD treatments and found that, although the risk of psychosis is low, it is greater for patients who are taking amphetamines than for those taking methylphenidates.", "summary_detail": {"type": "text/html", "language": null, "base": "https://www.sciencedaily.com/rss/health_medicine/pharmacology.xml", "value": "Researchers evaluated the two most common ADHD treatments and found that, although the risk of psychosis is low, it is greater for patients who are taking amphetamines than for those taking methylphenidates."}, "published": "Wed, 20 Mar 2019 17:17:04 EDT", "published_parsed": [2019, 3, 20, 21, 17, 4, 2, 79, 0], "id": "https://www.sciencedaily.com/releases/2019/03/190320171704.htm", "guidislink": false}